Vaccination may combat Clostridium difficile

UK - Whilst the life-threatening Clostridium difficile is not absolutely resistant to antibiotics, after an individual has been infected the bacteria often reappears.

Photo: Vaccination may combat Clostridium difficile

Vaccination against it is therefore seen as the possible answer, and now results from initial trials of one made by Acambis, a Cambridge-based biotech company, have encouraged its scientists to discuss involvement of the National Health Service (NHS) in tests in hospitals this year.
Rather than targeting the infection, this developing vaccine focuses on the toxins produced by a C. difficile infection. Trials on 200 patients indicate that the vaccine was effective at combating one of the major toxins in 100% of cases and a second major toxin in 75% of cases.
It is hoped that a course of three injections will provide long-lasting protection for over a decade.

01.03.2008

More on the subject:
Read all latest stories

Related articles

Photo

Preventing endoscope contamination

Ways to enhance hygiene in endoscopy

Stringent endoscope cleaning between procedures is vital. However, with so many steps in the process – plus high demand for rapid turnaround of endoscopes – contamination and biofilm build-up are…

Photo

Computer vision

Innovative hand hygiene solution uses AI

Russian tech company Connectome.ai is bringing its innovative Directiva.ai hand hygiene teaching and monitoring system to two major clinics owned by the European Medical Center group, the leading…

Photo

COVID-19 disinfection

New insights into SARS-CoV-2 surface stability and temperature susceptibility

Surface disinfection has proved an effective method to control COVID-19 infection, as virologists from the Ruhr University Bochum (RUB) have shown. However, an effective disinfection strategy against…

Related products

UVentions – UVbase

Disinfection

UVentions – UVbase

UVENTIONS GmbH
Subscribe to Newsletter